Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,015 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PD-1 inhibitors plus anti-angiogenic therapy with or without intensity-modulated radiotherapy for advanced hepatocellular carcinoma: A propensity score matching study.
Su K, Guo L, Ma W, Wang J, Xie Y, Rao M, Zhang J, Li X, Wen L, Li B, Yang X, Song Y, Huang W, Chi H, Gu T, Xu K, Liu Y, Chen J, Wu Z, Jiang Y, Li H, Zeng H, Wang P, Feng X, Chen S, Yang B, Jin H, He K, Han Y. Su K, et al. Among authors: wen l. Front Immunol. 2022 Sep 23;13:972503. doi: 10.3389/fimmu.2022.972503. eCollection 2022. Front Immunol. 2022. PMID: 36211350 Free PMC article.
Effect of external beam radiation therapy versus transcatheter arterial chemoembolization for non-diffuse hepatocellular carcinoma (≥ 5 cm): a multicenter experience over a ten-year period.
Su K, Wang F, Li X, Chi H, Zhang J, He K, Wang Z, Wen L, Song Y, Chen J, Wu Z, Jiang Y, Li H, Gu T, Wang C, Li Y, Liu M, Guo Q, Xu K, Guo L, Han Y. Su K, et al. Among authors: wen l. Front Immunol. 2023 Sep 25;14:1265959. doi: 10.3389/fimmu.2023.1265959. eCollection 2023. Front Immunol. 2023. PMID: 37818373 Free PMC article.
Gamma knife radiosurgery versus transcatheter arterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a propensity score matching study.
Su K, Gu T, Xu K, Wang J, Liao H, Li X, Wen L, Song Y, Zhong J, He B, Liu X, He J, Liu Y, Li Q, Feng X, Chen S, Yang B, Huang W, Jin H, Luo X, Hu T, Chen J, Wu Z, Lu S, Zhang J, Rao M, Xie Y, Wang J, Zhu X, Chen L, Li B, Su S, Yang X, Wang J, Zeng H, Wang P, Yan M, Chen X, He K, Han Y. Su K, et al. Among authors: wen l. Hepatol Int. 2022 Aug;16(4):858-867. doi: 10.1007/s12072-022-10339-2. Epub 2022 Jun 21. Hepatol Int. 2022. PMID: 35729469 Free PMC article. Clinical Trial.
Heat-shock protein 90α is a potential prognostic and predictive biomarker in hepatocellular carcinoma: a large-scale and multicenter study.
Su K, Liu Y, Wang P, He K, Wang F, Chi H, Rao M, Li X, Wen L, Song Y, Zhang J, Gu T, Xu K, Li Q, Chen J, Wu Z, Li H, Huang W, Chen L, Tong J, Li H, Feng X, Chen S, Yang B, Jin H, Yang Y, Liu H, Yang C, Wu M, Xiong F, Peng K, Zhu L, Xu Y, Tang X, Tan Z, Luo X, Zheng H, Zhang Y, Guo L, Han Y. Su K, et al. Among authors: wen l. Hepatol Int. 2022 Oct;16(5):1208-1219. doi: 10.1007/s12072-022-10391-y. Epub 2022 Aug 16. Hepatol Int. 2022. PMID: 35972640 Free PMC article.
PD-1 Inhibitors Combined with Antiangiogenic Therapy with or Without Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Propensity Matching Analysis.
Li H, Su K, Guo L, Jiang Y, Xu K, Gu T, Chen J, Wu Z, Wang P, Zhang X, Yan Y, Li S, Wu X, Han L, He K, Wen L, Li B, Han Y. Li H, et al. Among authors: wen l. J Hepatocell Carcinoma. 2023 Jul 29;10:1257-1266. doi: 10.2147/JHC.S415843. eCollection 2023. J Hepatocell Carcinoma. 2023. PMID: 37538403 Free PMC article.
Thymidine kinase 1 appears to be a marker for the prognosis of hepatocellular carcinoma based on a large-scale, multicenter study.
Jiang Y, Guo L, Han L, Li H, Li C, Wen L, Song Y, Wang Z, Wang P, Guo Q, Zhao W, Liu M, Chen J, Wu Z, Yan Y, Xu K, Gu T, Wu X, He K, Su K, Han Y. Jiang Y, et al. Among authors: wen l. J Cancer Res Clin Oncol. 2023 Nov;149(15):14271-14282. doi: 10.1007/s00432-023-05089-z. Epub 2023 Aug 10. J Cancer Res Clin Oncol. 2023. PMID: 37561208
5,015 results